XML 22 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Note 6 - Equity Incentive Plan
3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
6.
 
Equity Incentive Plan
 
The Company estimates the fair value of stock options and stock appreciation rights (“SARs”) using the Black-Scholes valuation model. Fair value of restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) are measured by the grant-date price of the Company’s shares. Fair value of performance restricted stock units (“PSUs”) is measured by the grant-date price of the Company’s shares with corresponding compensation cost recognized over the requisite service period. Compensation cost is recognized based on the estimated probabilities of achieving the performance goals. Changes to the probability assessment and the estimated shares expected to vest will result in adjustments to the related compensation cost that will be recorded in the period of the change. If the performance targets are
not
achieved,
no
compensation cost is recognized and any previously recognized compensation cost is reversed. 
 
The fair value of each stock option award during the
three
-month periods ended
March 31, 2019
and
2018
was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:
 
    Three Months Ended March 31,
    2019   2018
Risk free interest rate  
2.44%
-
2.54%
 
2.15%
-
2.37%
Expected volatility  
44.34%
-
44.41%
 
38.74%
-
40.81%
Expected life (years)  
 
3.5
 
 
 
4.5
 
Expected dividend yield  
 
0.00%
 
 
 
0.00%
 
 
The Company recorded
$1.4
million and
$7.6
million of stock-based compensation expense for the
three
-month periods ended
March 31, 2019
and
2018,
respectively. Upon the retirement of the Company’s former Chief Executive Officer on
March 9, 2018,
all of his outstanding stock-based compensation awards vested in full and became exercisable in accordance with their terms, resulting in a
one
-time expense of
$6.2
million that was fully recognized during the
three
-month period ended
March 31, 2018.
  
The Company presents the expenses related to stock-based compensation awards in the same expense line items as cash compensation paid to each of its employees as follows:
 
    Three Months Ended March 31,
    2019   2018
Cost of product revenue   $
92
    $
(216
)
Research & development    
177
     
210
 
Selling, general & administrative    
1,117
     
7,571
 
Total stock-based compensation expense   $
1,386
    $
7,565
 
 
The following table sets forth share information for stock-based compensation awards granted and exercised during the
three
-month periods ended
March 31, 2019
and
2018:
 
    Three Months Ended March 31,
    2019   2018
Grants:                
Stock Options    
104,292
     
192,300
 
RSAs    
     
64,578
 
RSUs    
165,507
     
8,130
 
PSUs    
114,500
     
 
Exercises:                
Stock Options    
500
     
11,425
 
SARs    
     
 
 
During the
three
-month period ended
March 31, 2019,
the Company granted stock-based compensation awards in the form of stock options, PSUs and RSUs to employees and RSUs to non-employee directors, the majority of which become exercisable or vest ratably over a
three
-year period. The PSUs granted to employees contained performance conditions with business and financial targets. The business target, amounting to
30%
of the total performance conditions, will be measured based on achievement in the
2019
fiscal year, while the financial targets, amounting to
70%
of the total performance conditions, will ultimately be measured with respect to the Company’s operating results in the
2021
fiscal year. The Company recorded
$0.1
million of stock-based compensation expense associated with PSUs for the
three
-month period ended
March 31, 2019.